Oncolytics Biotech (ONCY) Profit After Tax (2009 - 2025)
Oncolytics Biotech's (ONCY) quarterly Profit After Tax came in at -$10.5 million in Q3 2025, down 49.57% year-on-year from -$20.8 million in Q3 2024, and down 135.17% on a QoQ basis from -$4.4 million in Q2 2025.
Oncolytics Biotech (ONCY) Profit After Tax (2009 - 2025) Analysis & Trends
Oncolytics Biotech (ONCY) has 17 years of Profit After Tax data on file, last reported at -$10.5 million in Q3 2025.
- On a quarterly basis, Profit After Tax fell 49.57% year-over-year to -$10.5 million in Q3 2025; TTM through Sep 2025 was -$25.3 million, a 24.58% decrease from a year earlier, with the FY2025 full-year figure at -$28.9 million, down 23.91% from the prior year.
- Profit After Tax for Q3 2025 stood at -$10.5 million, down from -$4.4 million in the prior quarter.
- Over the last five years, Profit After Tax for ONCY reached as high as -$2.9 million in Q4 2023 and fell as low as -$10.5 million in Q3 2025.
- Historically, Profit After Tax has averaged -$5.4 million across 5 years, with a median of -$5.3 million in 2024.
- Across the five-year window, Profit After Tax slumped 537.47% in 2021 and jumped 53.97% in 2023, its largest moves.
- Year by year, Profit After Tax stood at -$6.1 million in 2021, then slipped by 2.48% to -$6.3 million in 2022, then surged by 53.97% to -$2.9 million in 2023, then plunged by 97.85% to -$5.7 million in 2024, then tumbled by 82.32% to -$10.5 million in 2025.
- Per Business Quant data, the three most recent Profit After Tax figures were -$10.5 million in Q3 2025, -$4.4 million in Q2 2025, and -$4.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Oncolytics Biotech | 372.40 Mn | 372.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.46 Mn |
| Jun 30, 2025 | -4.45 Mn |
| Mar 31, 2025 | -4.66 Mn |
| Dec 31, 2024 | -5.74 Mn |
| Sep 30, 2024 | -7.00 Mn |
| Jun 30, 2024 | -5.31 Mn |
| Mar 31, 2024 | -5.12 Mn |
| Dec 31, 2023 | -2.90 Mn |
| Sep 30, 2023 | -7.40 Mn |
| Jun 30, 2023 | -5.54 Mn |
| Mar 31, 2023 | -4.76 Mn |
| Dec 31, 2022 | -6.30 Mn |
| Sep 30, 2022 | -3.38 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -5.35 Mn |
| Dec 31, 2021 | -6.15 Mn |
| Sep 30, 2021 | -3.87 Mn |
| Jun 30, 2021 | -5.89 Mn |
| Mar 31, 2021 | -5.08 Mn |
| Dec 31, 2020 | -7.16 Mn |